‘Cancer vaccine’ study from scientists

gave | Monday, March 01, 2021 – 8:56 | Last Updated: 01 03 2021 – 8:56

At MERSIN University (MEU), 18 academics competent in the field of cancer studies came together for the cancer vaccine. It is aimed to minimize the side effects of cancer drugs by developing a personalized treatment method with the vaccine.

The oncology group established for cancer studies within MEU will develop a new treatment method in order to minimize the side effects that occur in cancer treatment. The manager of the Faculty of Arts and Sciences, Department of Biotechnology, Assoc. Dr. A special budget of 1 million TL was allocated for the project to be carried out by Furkan Ayaz. It is aimed to produce an effective solution against cancer and to minimize the side effects of cancer drugs with the treatment method, which is aimed to be individualized. Assoc. Dr. “The correct use of several types of individual and immune system cells can significantly increase the effectiveness of the treatment. We aim to finalize the project within three years and move to the stage of animal experiments and clinical trials,” said Ayaz.


Stating that a treatment method with high efficiency and high efficiency has not yet been developed for cancer, Assoc. Dr. Furkan Ayaz said, “Although radiation therapy and chemotherapy are among the most commonly used cancer treatment methods, they have deficiencies in terms of side effects and the improvement of the patient’s condition in real terms. In this context, it is important to develop new treatment methods against cancer. The general purpose of these treatments was to program the immune system cells correctly against the tumor cells, he said.


Noting that 18 academics competent in the field of cancer studies came together within the scope of the cancer vaccine or immunotherapy method project, Assoc. Dr. Ayaz said, “The project team includes academicians who specialize in lung, breast, colon, prostate, ovarian and various blood cancers. Rector Prof. Dr. Ahmet Çamsar’s special budget of 1 million TL will be finalized within three years and the animal experiments and clinical trials are carried out. Within the framework of the method, the cancerous tissue will be isolated and the individual’s immune system cells will be educated against the disease outside and given back to the body. Thus, we expect the immune cells to develop a response specific to the cancerous region and create a memory. Recurrence of the disease will be prevented. The main purpose here is not to introduce foreign chemicals into the body. We set our experimental design accordingly. We ensure that the patient receives a foreign chemical and provides treatment without side effects.